Salt Substitution Reduces Stroke Recurrence and Mortality: SSaSS Trial Highlights Cost-Effective Prevention Strategy
China: A recent randomized clinical trial has highlighted the potential health benefits of replacing regular salt with a salt substitute in individuals with a history of stroke. The study, published in JAMA Cardiology, found that using a salt substitute proved to be a safe intervention. It significantly lowered the risk of recurrent stroke and mortality, reinforcing its role as a cost-effective strategy for stroke prevention.
Stroke is a leading cause of disability and death worldwide, with high sodium intake being a well-established risk factor for hypertension, which in turn contributes to stroke recurrence. Given the widespread consumption of salt in daily diets, replacing it with a lower-sodium alternative could have significant public health implications. Considering this, Xiong Ding, School of Public Health, Wuhan University, Wuhan, China, and colleagues aimed to assess the impact of salt substitutes compared to regular salt on recurrent stroke incidence and mortality in patients with a history of stroke.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.